| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/12/2003 | EP1360331A2 Vector system used in screening active substances |
| 11/12/2003 | EP1360327A1 Method for identifying genes regulating desired cell phenotypes |
| 11/12/2003 | EP1360326A2 Cell based triple readout assay systems for identifying compounds that affect transcription |
| 11/12/2003 | EP1360325A2 Multiplex quantification of nucleic acids in diseased cells |
| 11/12/2003 | EP1360322A2 Detection of microsatellite instability and its use in diagnosis of tumors |
| 11/12/2003 | EP1360319A2 Diagnosis of diseases associated with metabolism |
| 11/12/2003 | EP1360318A2 Method of detection by enhancement of silver staining |
| 11/12/2003 | EP1360317A2 Detection of aberrant dna methylation as marker for human cancer |
| 11/12/2003 | EP1360313A2 Carotenoid biosynthesis |
| 11/12/2003 | EP1360312A1 Method for l-threonine production |
| 11/12/2003 | EP1360311A2 Membrane penetrating peptides and uses thereof |
| 11/12/2003 | EP1360310A2 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| 11/12/2003 | EP1360309A2 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 11/12/2003 | EP1360308A2 Concatemers of differentially expressed multiple genes |
| 11/12/2003 | EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 11/12/2003 | EP1360306A2 Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same |
| 11/12/2003 | EP1360305A2 A process for the fermentative preparation of d-pantothenic acid and/or its salts |
| 11/12/2003 | EP1360304A2 Enzymes |
| 11/12/2003 | EP1360303A2 Process for the fermentative production of d-pantothenic acid |
| 11/12/2003 | EP1360302A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 11/12/2003 | EP1360301A2 Genes involved in isoprenoid compound production |
| 11/12/2003 | EP1360300A2 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms |
| 11/12/2003 | EP1360299A2 The genome of a bifidobacterium |
| 11/12/2003 | EP1360298A2 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum |
| 11/12/2003 | EP1360297A2 Ragweed allergens |
| 11/12/2003 | EP1360296A2 Method for the production of plant seed with modified fibre content and modified seed coat |
| 11/12/2003 | EP1360295A2 Molecules for desease detection and treatment |
| 11/12/2003 | EP1360294A2 Regulation of human dorsal root receptor-like g protein-coupled receptor |
| 11/12/2003 | EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 11/12/2003 | EP1360292A2 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 11/12/2003 | EP1360291A2 Human polynucleotides and polypeptides encoded thereby |
| 11/12/2003 | EP1360290A2 Co-stimulatory molecules |
| 11/12/2003 | EP1360289A1 Method of eukaryotic expression cloning of disease associated molecules |
| 11/12/2003 | EP1360288A2 Focused libraries of genetic packages |
| 11/12/2003 | EP1360287A1 Methods of modifying eukaryotic cells |
| 11/12/2003 | EP1360286A2 Characterization of the gsk-3beta protein and methods of use thereof |
| 11/12/2003 | EP1360284A2 Recombinant proteinase k |
| 11/12/2003 | EP1360283A2 Expression of recombinant proteinase k from i tritirachium album /i in yeast |
| 11/12/2003 | EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 11/12/2003 | EP1360278A2 Lipase variants |
| 11/12/2003 | EP1360277A2 Multipotent o-2a progenitors from the neurohypophysis |
| 11/12/2003 | EP1360276A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 11/12/2003 | EP1360206A2 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof |
| 11/12/2003 | EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 11/12/2003 | EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis |
| 11/12/2003 | EP1360199A2 Treatment involving dkk-1 or antagonists thereof |
| 11/12/2003 | EP1360198A2 Novel polypeptides and nucleic acids encoded thereby |
| 11/12/2003 | EP1360197A2 Histidine phosphatase interacting protein with 240kd |
| 11/12/2003 | EP1360196A2 Improved method for production of secreted proteins in fungi |
| 11/12/2003 | EP1360195A2 H. influenzae antigen basb213 |
| 11/12/2003 | EP1360194A2 Systems for expression of heterologous proteins in m. capsulatus |
| 11/12/2003 | EP1360193A1 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 11/12/2003 | EP1360191A2 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo |
| 11/12/2003 | EP1359938A2 Method for treating psoriasis by using an il-17d antagonist |
| 11/12/2003 | EP1359937A1 Altered peptide ligands |
| 11/12/2003 | EP1359932A2 Tip39 polypeptides |
| 11/12/2003 | EP1359797A1 Human sphingosine-1-phosphate phosphatase |
| 11/12/2003 | EP1196637A4 Peptide acceptor ligation methods |
| 11/12/2003 | EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 11/12/2003 | EP1084257B1 A STRAIN E.COLI JM83/pKP2 TRANSFORMED WITH A NOVEL PLASMID AND PHYTASE PRODUCED THEREFROM |
| 11/12/2003 | EP1077830B1 Vehicle seat assembly with thermoformed fibrous suspension panel |
| 11/12/2003 | EP1007624B1 Ds11 (kctc 0231bp), novel bacillus sp. strain and novel phytase produced by it |
| 11/12/2003 | EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 11/12/2003 | EP0938574B1 Method for inducing viral resistance into a plant |
| 11/12/2003 | EP0897390B1 Human tumor necrosis factor delta and epsilon |
| 11/12/2003 | EP0847272B1 LIPOSOMAL p-ETHOXY OLIGONUCLEOTIDES |
| 11/12/2003 | EP0840742A4 Systematic evolution of ligands by exponential enrichment: chemi-selex |
| 11/12/2003 | EP0775203B1 Method of gene therapy using dna vectors without selection marker gene |
| 11/12/2003 | EP0773952B1 Interaction trap systems for detecting protein interactions |
| 11/12/2003 | EP0767837B1 Increased production of beta-galactosidase in aspergillus oryzae |
| 11/12/2003 | EP0759759B1 P75 tnf receptor promoters |
| 11/12/2003 | EP0742829B1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
| 11/12/2003 | EP0741515B1 Transgenic production of antibodies in milk |
| 11/12/2003 | EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications |
| 11/12/2003 | CN1455817A Methods for replacement, translocation and stacking of DNA in eukaryotic genomes |
| 11/12/2003 | CN1455816A Rescue of canine distemper virus from CDNA |
| 11/12/2003 | CN1455815A Malaria plasmodium antigen polypeptide SE36, method of purifying same and vaccine and diagnosis with use of obtained antigen |
| 11/12/2003 | CN1455814A Polynucleotide probe and primer originating in hepatitis E virus of Japanese, chips having the same, kits having the same and method for detecting thereof |
| 11/12/2003 | CN1455813A Human myeloma cell line |
| 11/12/2003 | CN1455682A Compositions for gene therapy of rheumatoid arthritis including gene encoding anti-angiogenic protein or parts thereof |
| 11/12/2003 | CN1455680A MUCl extracellular domain and cancer treatment compositions and methods derived therefrom |
| 11/12/2003 | CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine |
| 11/12/2003 | CN1455668A Gene conferring resistance to antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same and applications thereof |
| 11/12/2003 | CN1455001A Exendin-4 polypeptide preparation method |
| 11/12/2003 | CN1454998A Method of conducting plant seed transgene using transverse alternating pulse electrophoresis |
| 11/12/2003 | CN1454997A Rape sodium-hydrogen pump transport protein coding sequence and application thereof |
| 11/12/2003 | CN1454996A Screening non-infective virus recombinant gene SARS-Cov-EGFP for medicine of anti SARS coronavirus |
| 11/12/2003 | CN1454991A Method of increasing super rice yield applying transgene technique |
| 11/12/2003 | CN1454989A Yeast genetically engineered strain expressing hrp gene and constructing method thereof |
| 11/12/2003 | CN1454988A Humicole uspergillus |
| 11/12/2003 | CN1454900A Glucose and insulin response element |
| 11/12/2003 | CN1127571C Permentative production of valuable compounds on industrial scale using chemically defined media |
| 11/12/2003 | CN1127570C Use of castor silkworm cell nucleus and skeleton combination elements |
| 11/12/2003 | CN1127569C Method for mass production of antimicrobial peptide |
| 11/12/2003 | CN1127568C Fibroblast growth factor homologs |
| 11/12/2003 | CN1127517C Trophic fuctors for central nervous system |
| 11/12/2003 | CN1127516C Novel polypeptides |
| 11/12/2003 | CN1127351C Method for inducing antigen-specific T cell tolerance |
| 11/12/2003 | CN1127343C Myoblast therapy for mammalian diseases |
| 11/11/2003 | USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex |